GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)

 MET_ECHTE               Reviewed;        1380 AA.
A1X150;
06-MAR-2007, integrated into UniProtKB/Swiss-Prot.
06-FEB-2007, sequence version 1.
07-APR-2021, entry version 76.
RecName: Full=Hepatocyte growth factor receptor;
Short=HGF receptor;
EC=2.7.10.1;
AltName: Full=HGF/SF receptor;
AltName: Full=Proto-oncogene c-Met;
AltName: Full=Scatter factor receptor;
Short=SF receptor;
AltName: Full=Tyrosine-protein kinase Met;
Flags: Precursor;
Name=MET;
Echinops telfairi (Lesser hedgehog tenrec).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
Eutheria; Afrotheria; Tenrecidae; Tenrecinae; Echinops.
NCBI_TaxID=9371;
[1]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Antonellis A., Ayele K., Benjamin B., Blakesley R.W., Boakye A.,
Bouffard G.G., Brinkley C., Brooks S., Chu G., Coleman H., Engle J.,
Gestole M., Greene A., Guan X., Gupta J., Haghighi P., Han J., Hansen N.,
Ho S.-L., Hu P., Hunter G., Hurle B., Idol J.R., Kwong P., Laric P.,
Larson S., Lee-Lin S.-Q., Legaspi R., Madden M., Maduro Q.L., Maduro V.B.,
Margulies E.H., Masiello C., Maskeri B., McDowell J., Mojidi H.A.,
Mullikin J.C., Oestreicher J.S., Park M., Portnoy M.E., Prasad A., Puri O.,
Reddix-Dugue N., Schandler K., Schueler M.G., Sison C., Stantripop S.,
Stephen E., Taye A., Thomas J.W., Thomas P.J., Tsipouri V., Ung L.,
Vogt J.L., Wetherby K.D., Young A., Green E.D.;
"NISC comparative sequencing initiative.";
Submitted (DEC-2006) to the EMBL/GenBank/DDBJ databases.
-!- FUNCTION: Receptor tyrosine kinase that transduces signals from the
extracellular matrix into the cytoplasm by binding to hepatocyte growth
factor/HGF ligand. Regulates many physiological processes including
proliferation, scattering, morphogenesis and survival. Ligand binding
at the cell surface induces autophosphorylation of MET on its
intracellular domain that provides docking sites for downstream
signaling molecules. Following activation by ligand, interacts with the
PI3-kinase subunit PIK3R1, PLCG1, SRC, GRB2, STAT3 or the adapter GAB1.
Recruitment of these downstream effectors by MET leads to the
activation of several signaling cascades including the RAS-ERK, PI3
kinase-AKT, or PLCgamma-PKC. The RAS-ERK activation is associated with
the morphogenetic effects while PI3K/AKT coordinates prosurvival
effects. During embryonic development, MET signaling plays a role in
gastrulation, development and migration of muscles and neuronal
precursors, angiogenesis and kidney formation. In adults, participates
in wound healing as well as organ regeneration and tissue remodeling.
Promotes also differentiation and proliferation of hematopoietic cells
(By similarity). {ECO:0000250}.
-!- CATALYTIC ACTIVITY:
Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
[protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
-!- ACTIVITY REGULATION: In its inactive state, the C-terminal tail
interacts with the catalytic domain and inhibits the kinase activity.
Upon ligand binding, the C-terminal tail is displaced and becomes
phosphorylated, thus increasing the kinase activity (By similarity).
{ECO:0000250}.
-!- SUBUNIT: Heterodimer made of an alpha chain (50 kDa) and a beta chain
(145 kDa) which are disulfide linked. Binds PLXNB1. Interacts when
phosphorylated with downstream effectors including STAT3, PIK3R1, SRC,
PCLG1, GRB2 and GAB1. Interacts with SPSB1, SPSB2 and SPSB4. Interacts
with INPP5D/SHIP1. When phosphorylated at Tyr-1355, interacts with
INPPL1/SHIP2. Interacts with RANBP9 and RANBP10, as well as SPSB1,
SPSB2, SPSB3 and SPSB4. SPSB1 binding occurs in the presence and in the
absence of HGF, however HGF treatment has a positive effect on this
interaction. Interacts with MUC20; prevents interaction with GRB2 and
suppresses hepatocyte growth factor-induced cell proliferation.
Interacts with GRB10. Interacts with PTPN1 and PTPN2. Interacts with
HSP90AA1 and HSP90AB1; the interaction suppresses MET kinase activity.
{ECO:0000250|UniProtKB:P08581, ECO:0000250|UniProtKB:P16056}.
-!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass type I
membrane protein {ECO:0000250}.
-!- DOMAIN: The kinase domain is involved in SPSB1 binding. {ECO:0000250}.
-!- DOMAIN: The beta-propeller Sema domain mediates binding to HGF.
{ECO:0000250}.
-!- PTM: Autophosphorylated in response to ligand binding on Tyr-1233 and
Tyr-1234 in the kinase domain leading to further phosphorylation of
Tyr-1348 and Tyr-1355 in the C-terminal multifunctional docking site.
Dephosphorylated by PTPRJ at Tyr-1348 and Tyr-1364. Dephosphorylated by
PTPN1 and PTPN2 (By similarity). {ECO:0000250}.
-!- PTM: Ubiquitinated. Ubiquitination by CBL regulates the receptor
stability and activity through proteasomal degradation (By similarity).
{ECO:0000250}.
-!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
---------------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
---------------------------------------------------------------------------
EMBL; DP000274; ABL76166.1; -; Genomic_DNA.
SMR; A1X150; -.
OMA; DEEPGQC; -.
GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
GO; GO:0017154; F:semaphorin receptor activity; IEA:InterPro.
GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IEA:UniProtKB-EC.
GO; GO:0050918; P:positive chemotaxis; ISS:UniProtKB.
GO; GO:2001028; P:positive regulation of endothelial cell chemotaxis; ISS:UniProtKB.
GO; GO:0071526; P:semaphorin-plexin signaling pathway; ISS:UniProtKB.
GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IEA:InterPro.
Gene3D; 2.130.10.10; -; 1.
Gene3D; 2.60.40.10; -; 3.
InterPro; IPR013783; Ig-like_fold.
InterPro; IPR014756; Ig_E-set.
InterPro; IPR002909; IPT_dom.
InterPro; IPR011009; Kinase-like_dom_sf.
InterPro; IPR031148; Plexin.
InterPro; IPR002165; Plexin_repeat.
InterPro; IPR000719; Prot_kinase_dom.
InterPro; IPR017441; Protein_kinase_ATP_BS.
InterPro; IPR016201; PSI.
InterPro; IPR001627; Semap_dom.
InterPro; IPR036352; Semap_dom_sf.
InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
InterPro; IPR008266; Tyr_kinase_AS.
InterPro; IPR020635; Tyr_kinase_cat_dom.
InterPro; IPR016244; Tyr_kinase_HGF/MSP_rcpt.
InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
PANTHER; PTHR22625; PTHR22625; 1.
Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
Pfam; PF01437; PSI; 1.
Pfam; PF01403; Sema; 1.
Pfam; PF01833; TIG; 3.
PIRSF; PIRSF000617; TyrPK_HGF-R; 1.
PRINTS; PR00109; TYRKINASE.
SMART; SM00429; IPT; 4.
SMART; SM00423; PSI; 1.
SMART; SM00630; Sema; 1.
SMART; SM00219; TyrKc; 1.
SUPFAM; SSF101912; SSF101912; 1.
SUPFAM; SSF56112; SSF56112; 1.
SUPFAM; SSF81296; SSF81296; 3.
PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PROSITE; PS51004; SEMA; 1.
3: Inferred from homology;
ATP-binding; Disulfide bond; Glycoprotein; Kinase; Membrane;
Nucleotide-binding; Phosphoprotein; Proto-oncogene; Receptor; Repeat;
Signal; Transferase; Transmembrane; Transmembrane helix;
Tyrosine-protein kinase; Ubl conjugation.
SIGNAL 1..24
/evidence="ECO:0000255"
CHAIN 25..1380
/note="Hepatocyte growth factor receptor"
/id="PRO_0000280067"
TOPO_DOM 25..931
/note="Extracellular"
/evidence="ECO:0000255"
TRANSMEM 932..954
/note="Helical"
/evidence="ECO:0000255"
TOPO_DOM 955..1380
/note="Cytoplasmic"
/evidence="ECO:0000255"
DOMAIN 27..513
/note="Sema"
/evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
DOMAIN 561..654
/note="IPT/TIG 1"
DOMAIN 656..738
/note="IPT/TIG 2"
DOMAIN 741..835
/note="IPT/TIG 3"
DOMAIN 1077..1344
/note="Protein kinase"
/evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
NP_BIND 1083..1091
/note="ATP"
/evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
REGION 1211..1380
/note="Interaction with RANBP9"
/evidence="ECO:0000250"
REGION 1319..1358
/note="Interaction with MUC20"
/evidence="ECO:0000250"
ACT_SITE 1203
/note="Proton acceptor"
/evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
ECO:0000255|PROSITE-ProRule:PRU10028"
BINDING 1109
/note="ATP"
/evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
SITE 305..306
/note="Cleavage"
/evidence="ECO:0000255"
MOD_RES 965
/note="Phosphoserine"
/evidence="ECO:0000250|UniProtKB:P08581"
MOD_RES 976
/note="Phosphothreonine"
/evidence="ECO:0000250|UniProtKB:P08581"
MOD_RES 989
/note="Phosphoserine"
/evidence="ECO:0000250|UniProtKB:P08581"
MOD_RES 996
/note="Phosphoserine"
/evidence="ECO:0000250|UniProtKB:P08581"
MOD_RES 999
/note="Phosphoserine"
/evidence="ECO:0000250|UniProtKB:P08581"
MOD_RES 1002
/note="Phosphotyrosine"
/evidence="ECO:0000250|UniProtKB:P08581"
MOD_RES 1229
/note="Phosphotyrosine"
/evidence="ECO:0000250|UniProtKB:P08581"
MOD_RES 1233
/note="Phosphotyrosine; by autocatalysis"
/evidence="ECO:0000250|UniProtKB:P08581"
MOD_RES 1234
/note="Phosphotyrosine; by autocatalysis"
/evidence="ECO:0000250|UniProtKB:P08581"
MOD_RES 1288
/note="Phosphothreonine"
/evidence="ECO:0000250|UniProtKB:P08581"
MOD_RES 1348
/note="Phosphotyrosine; by autocatalysis"
/evidence="ECO:0000250|UniProtKB:P08581"
MOD_RES 1355
/note="Phosphotyrosine; by autocatalysis"
/evidence="ECO:0000250|UniProtKB:P08581"
MOD_RES 1364
/note="Phosphotyrosine"
/evidence="ECO:0000250|UniProtKB:P08581"
CARBOHYD 45
/note="N-linked (GlcNAc...) asparagine"
/evidence="ECO:0000255"
CARBOHYD 200
/note="N-linked (GlcNAc...) asparagine"
/evidence="ECO:0000255"
CARBOHYD 397
/note="N-linked (GlcNAc...) asparagine"
/evidence="ECO:0000255"
CARBOHYD 403
/note="N-linked (GlcNAc...) asparagine"
/evidence="ECO:0000255"
CARBOHYD 551
/note="N-linked (GlcNAc...) asparagine"
/evidence="ECO:0000255"
CARBOHYD 592
/note="N-linked (GlcNAc...) asparagine"
/evidence="ECO:0000255"
CARBOHYD 605
/note="N-linked (GlcNAc...) asparagine"
/evidence="ECO:0000255"
CARBOHYD 633
/note="N-linked (GlcNAc...) asparagine"
/evidence="ECO:0000255"
CARBOHYD 784
/note="N-linked (GlcNAc...) asparagine"
/evidence="ECO:0000255"
CARBOHYD 878
/note="N-linked (GlcNAc...) asparagine"
/evidence="ECO:0000255"
CARBOHYD 929
/note="N-linked (GlcNAc...) asparagine"
/evidence="ECO:0000255"
DISULFID 95..101
/evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
DISULFID 98..156
/evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
DISULFID 129..137
/evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
DISULFID 170..173
/evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
DISULFID 296..361
/evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
DISULFID 383..395
/evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
DISULFID 518..536
/evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
DISULFID 524..559
/evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
DISULFID 527..543
/evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
DISULFID 539..549
/evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
SEQUENCE 1380 AA; 153466 MW; 32D24F67032BF2D8 CRC64;
MKAPAALAPG ILVLLLTLVQ KGGGECREAL AKSEMNVNMR YRLPNFTADT PIQNVVVHEG
HVFLGAINSI YVLRERDLQQ VSEYKTGPVW EHPDCLPCQA CGLAGGQWRE NVNMALLVET
YYDDQLISCG SVHRGTCQRH VLPRDNPADI QAEVHCMHSP RADEDEASQC PDCVVSALGT
KVLLAEKQRF VNFFVGNTLN GSSLPGHALH SISVRRIKET QDGFKFLTDK SYIDVLPEFQ
ASYPIKYIHA FESNRFIYFL TVQRETLDSP SFHTRIIRFC SADSGLRSYM EMPLECILTE
KRRKRALRSE VFNVLQAAYV GKPGAQLAKQ IGASAHDDIL YGVFSQSRPD SAEPTDRSAL
CAFPVKYVDE FFHRIVNKNN VRCLQHFYGP NHLHCFNRTL LRNSSGCEVR SDEYRTEFTT
ALQRIDLSAG HFSQVLLTSI STFIKGDLTI ANLGTSEGRF MQVVVSRSGS WTPHVDFRLD
SHAVSPEVIV EHPVNQNGYT LVVTGKKITK IPLDGLGCEH FQSCSQCLSA PPFVQCGWCH
DKCARAEDCP NGTWTQEICL PTIYEVFPAS APLEGGTTLT VCGWDFGFRR NNKSDFKRTR
VLIGNESCPL TLSESTPNML KCTVGPAMSE HSNLSIIISN VRGTAPQYRT FSYVDPEITS
ISPSYGPKAG GTLVTLTGKY LNSGNSRHIS IGGKTCTLKS VSDSVLECYT PAQSISADFP
VKLKIDLANR EAYSFSYQEN PLVVEIHPTK SFVSGGSTIT VVGKNLNSVS VPRMIINVHE
VEMNFTVACQ QRSNSELICC TTPSLQQLDL QLPLKATAFF MLDGIHSRDF DLIYVPNPVF
KLFEKPVMIS MGNENVLEIK GNDIDPEAVK GEVLKVGNKS CENIHSYPES VLCTVPNDLL
KLNSELNIEW KQAVSSTVLG KVIVQPDQNF TGLIVGVVSI SVILLSSLGL FLWLKKRKQI
KDLGSELVCY DARVHTPHLD RLVSARSVSP TTEMVSNESV DYRATFPEDQ FPNSSQNGSC
RQVQYPLPDL SPILTSGDSD ISSPLLQNTV HIDLSALNPE LVQAVQHVVI GPSSLIVHFN
EVIGRGHFGC VYHGTLLDND DRKIHCAVKS LNRITDIGEV SQFLTEGIIM KDFSHPNVLS
LLGICLRSEG SPLVVLPYMK HGDLRNFIRN ETHSPTVKDL IGFGLQVAKG MKYLASKKFV
HRDLAARNCM LDGKFTVKVA DFGLARDMYD KEYYSVHNKT GAKLPVKWMA LESLQTQKFT
TKSDVWSFGV LLWELMTRGA PPYPDVNTFD ITVYLLQGRR LLQPEYCPDP LYEVMLKCWH
PKAEMRPSFT ELVSRISAIF STFIGEHYVH VNATYVNVKC VAPYPSLLSS HDTVDGEVDT


Related products :

Catalog number Product name Quantity
18-785-210279 Met (Ab-1234) - EC 2.7.10.1; HGF receptor; Scatter factor receptor; SF receptor; HGF_SF receptor; Met proto-oncogene tyrosine kinase; c-Met Polyclonal 0.05 mg
18-785-210279 Met (Ab-1234) - EC 2.7.10.1; HGF receptor; Scatter factor receptor; SF receptor; HGF_SF receptor; Met proto-oncogene tyrosine kinase; c-Met Polyclonal 0.1 mg
18-785-210280 Met (Ab-1349) - EC 2.7.10.1; HGF receptor; Scatter factor receptor; SF receptor; HGF_SF receptor; Met proto-oncogene tyrosine kinase; c-Met Polyclonal 0.05 mg
10-054-165010 cMet HUMAN - EC 2.7.10.1; HGF receptor; Scatter factor receptor; SF receptor; HGF_SF receptor; Met proto-oncogene tyrosine kinase; c-Met 0.01 mg
18-785-210280 Met (Ab-1349) - EC 2.7.10.1; HGF receptor; Scatter factor receptor; SF receptor; HGF_SF receptor; Met proto-oncogene tyrosine kinase; c-Met Polyclonal 0.1 mg
18-785-210277 Met (Phospho-Tyr1234) - EC 2.7.10.1; HGF receptor; Scatter factor receptor; SF receptor; HGF_SF receptor; Met proto-oncogene tyrosine kinase; c-Met Polyclonal 0.05 mg
18-785-210278 Met (Phospho-Tyr1349) - EC 2.7.10.1; HGF receptor; Scatter factor receptor; SF receptor; HGF_SF receptor; Met proto-oncogene tyrosine kinase; c-Met Polyclonal 0.1 mg
18-785-210277 Met (Phospho-Tyr1234) - EC 2.7.10.1; HGF receptor; Scatter factor receptor; SF receptor; HGF_SF receptor; Met proto-oncogene tyrosine kinase; c-Met Polyclonal 0.1 mg
18-785-210278 Met (Phospho-Tyr1349) - EC 2.7.10.1; HGF receptor; Scatter factor receptor; SF receptor; HGF_SF receptor; Met proto-oncogene tyrosine kinase; c-Met Polyclonal 0.05 mg
18-272-196210 Met ( c - Met ) - Rabbit polyclonal to Met ( c - Met ); EC 2.7.10.1; HGF receptor; Scatter factor receptor; SF receptor; HGF_SF receptor; Met proto-oncogene tyrosine kinase; c-Met Polyclonal 0.05 mg
18-272-195200 Met (c-Met) - Goat polyclonal to Met (c-Met); EC 2.7.10.1; HGF receptor; Scatter factor receptor; SF receptor; HGF_SF receptor; Met proto-oncogene tyrosine kinase; c-Met Polyclonal 0.025 mg
U0978r CLIA Epidermal growth factor receptor-related protein,Erbb2,Neu,p185erbB2,p185neu,Proto-oncogene c-ErbB-2,Proto-oncogene Neu,Rat,Rattus norvegicus,Receptor tyrosine-protein kinase erbB-2 96T
E0978r ELISA Epidermal growth factor receptor-related protein,Erbb2,Neu,p185erbB2,p185neu,Proto-oncogene c-ErbB-2,Proto-oncogene Neu,Rat,Rattus norvegicus,Receptor tyrosine-protein kinase erbB-2 96T
E0978r ELISA kit Epidermal growth factor receptor-related protein,Erbb2,Neu,p185erbB2,p185neu,Proto-oncogene c-ErbB-2,Proto-oncogene Neu,Rat,Rattus norvegicus,Receptor tyrosine-protein kinase erbB-2 96T
20-272-191078 Met ( c - Met ) ( phospho Y1234 ) - Mouse monoclonal [3i20] to Met ( c - Met ) ( phospho Y1234 ); EC 2.7.10.1; HGF receptor; Scatter factor receptor; SF receptor; HGF_SF receptor; Met proto-oncogene t 0.05 ml
U0757h CLIA EGFR,Epidermal growth factor receptor,ERBB1,Homo sapiens,Human,Proto-oncogene c-ErbB-1,Receptor tyrosine-protein kinase erbB-1 96T
E0757h ELISA EGFR,Epidermal growth factor receptor,ERBB1,Homo sapiens,Human,Proto-oncogene c-ErbB-1,Receptor tyrosine-protein kinase erbB-1 96T
E0757h ELISA kit EGFR,Epidermal growth factor receptor,ERBB1,Homo sapiens,Human,Proto-oncogene c-ErbB-1,Receptor tyrosine-protein kinase erbB-1 96T
EIAAB13163 Erbb3,Glial growth factor receptor,Mouse,Mus musculus,Proto-oncogene-like protein c-ErbB-3,Receptor tyrosine-protein kinase erbB-3
U0147m CLIA Embryonic receptor kinase 2,Emrk2,Flt,Flt1,FLT-1,Fms-like tyrosine kinase 1,Mouse,Mus musculus,Tyrosine-protein kinase receptor FLT,Vascular endothelial growth factor receptor 1,VEGFR-1 96T
E0147m ELISA Embryonic receptor kinase 2,Emrk2,Flt,Flt1,FLT-1,Fms-like tyrosine kinase 1,Mouse,Mus musculus,Tyrosine-protein kinase receptor FLT,Vascular endothelial growth factor receptor 1,VEGFR-1 96T
E0147m ELISA kit Embryonic receptor kinase 2,Emrk2,Flt,Flt1,FLT-1,Fms-like tyrosine kinase 1,Mouse,Mus musculus,Tyrosine-protein kinase receptor FLT,Vascular endothelial growth factor receptor 1,VEGFR-1 96T
18-783-75623 RABBIT ANTI HUMAN EGF RECEPTOR - EPIDERMAL GROWTH FACTOR RECEPTOR; EC 2.7.10.1; Receptor tyrosine-protein kinase ErbB-1 Polyclonal 0.05 mg
15-288-21181 Vascular endothelial growth factor receptor 2 - EC 2.7.10.1; VEGFR-2; Kinase insert domain receptor; Protein-tyrosine kinase receptor Flk-1; CD309 antigen Polyclonal 0.1 mg
15-288-21181 Vascular endothelial growth factor receptor 2 - EC 2.7.10.1; VEGFR-2; Kinase insert domain receptor; Protein-tyrosine kinase receptor Flk-1; CD309 antigen Polyclonal 0.05 mg
Pathways :
WP444: Signaling of Hepatocyte Growth Factor Receptor
WP193: Signaling of Hepatocyte Growth Factor Receptor
WP94: Signaling of Hepatocyte Growth Factor Receptor
WP810: Signaling of Hepatocyte Growth Factor Receptor
WP313: Signaling of Hepatocyte Growth Factor Receptor
WP1162: Signaling of Hepatocyte Growth Factor Receptor
WP1235: Signaling of Hepatocyte Growth Factor Receptor
WP1046: Signaling of Hepatocyte Growth Factor Receptor
WP1206: Signaling of Hepatocyte Growth Factor Receptor
WP927: Signaling of Hepatocyte Growth Factor Receptor
WP2292: Chemokine signaling pathway
WP2272: Pathogenic Escherichia coli infection
WP474: Endochondral Ossification
WP1354: B Cell Receptor Signaling Pathway
WP2079: Serotonin Receptor 2 and STAT3 Signaling
WP878: EPO Receptor Signaling
WP2328: Allograft rejection
WP1004: Kit Receptor Signaling Pathway
WP2355: Corticotropin-releasing hormone
WP733: Serotonin Receptor 2 and STAT3 Signaling
WP1025: B Cell Receptor Signaling Pathway
WP138: Androgen receptor signaling pathway
WP2118: Arrhythmogenic right ventricular cardiomyopathy
WP352: T Cell Receptor Signaling Pathway
WP894: T Cell Receptor Signaling Pathway

Related Genes :
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[Met] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[Met] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)

Bibliography :
No related Items